Ozempic is a once-weekly injectable prescription medication used to manage type 2 diabetes. Its active ingredient, semaglutide, mimics a natural gut hormone that regulates blood sugar, and it has gained widespread attention partly because it also causes significant weight loss. Ozempic is FDA-approved specifically for type 2 diabetes, not for weight management on its own, though a higher-dose version of the same drug (Wegovy) is approved for that purpose.
How Ozempic Works in Your Body
After you eat, your gut releases a hormone called GLP-1 that tells your pancreas to produce insulin. Semaglutide is a synthetic version of that hormone, sharing 94% of its structure with the natural version. But unlike the natural hormone, which breaks down within minutes, semaglutide is engineered to last about a week in your bloodstream.
Once it binds to GLP-1 receptors, semaglutide triggers several effects at once. It signals the pancreas to release more insulin, but only when blood sugar is actually elevated, which lowers the risk of dangerous blood sugar drops. It also suppresses glucagon, a hormone that raises blood sugar. On top of that, it slows the rate at which food leaves your stomach, so you feel full longer and eat less. This combination of effects is why people on Ozempic typically see both lower blood sugar readings and noticeable weight loss.
What Ozempic Is Approved to Treat
The FDA has approved Ozempic for three specific uses in adults with type 2 diabetes: managing blood sugar levels, reducing cardiovascular risk in those who also have heart disease, and improving kidney and cardiovascular health in those with chronic kidney disease. It is not approved as a standalone weight loss drug.
If your doctor is prescribing semaglutide primarily for weight loss, they would typically prescribe Wegovy instead. Wegovy is the same molecule but available at a slightly higher maximum dose (2.4 mg versus 2 mg for Ozempic) and carries its own set of approved uses: weight management in adults and children 12 and older, treatment of a specific type of fatty liver disease, and cardiovascular risk reduction in adults with obesity or overweight who also have heart disease.
How Well It Works for Blood Sugar
Across multiple large clinical trials known as the SUSTAIN program, Ozempic consistently lowered A1C, the measure of average blood sugar over roughly three months. Compared to other diabetes medications, the 0.5 mg dose reduced A1C by an additional 0.32 to 0.79 percentage points, while the 1 mg dose reduced it by 0.38 to 1.07 percentage points. To put that in context, an A1C drop of even half a percentage point is considered clinically meaningful, often enough to move someone from “uncontrolled” into a safer range.
Cardiovascular Benefits
One of the more compelling findings with semaglutide goes beyond blood sugar. A meta-analysis of trial data found it reduced the risk of major cardiovascular events (heart attack, stroke, or cardiovascular death combined) by 18%. Broken down further, it cut the risk of stroke by 32%, heart attack by 18%, and cardiovascular death by 23%. These reductions are substantial and are a major reason doctors prescribe Ozempic for patients with type 2 diabetes who are also at risk for heart problems.
Common Side Effects
Gastrointestinal problems are by far the most frequent complaint. In the STEP 4 trial, about 42% of participants on semaglutide reported some form of GI side effect, compared to 26% on placebo. Nausea is the most common, particularly in the first few weeks and after each dose increase. Vomiting, diarrhea, constipation, and stomach pain also occur. For most people, these symptoms are mild to moderate and tend to improve as the body adjusts over several weeks.
The gradual dose escalation schedule exists specifically to minimize these effects. Starting low gives your digestive system time to adapt before the dose increases.
The Thyroid Warning
Ozempic carries the FDA’s most serious warning label regarding thyroid tumors. In rodent studies, semaglutide caused a type of thyroid cancer called medullary thyroid carcinoma. Whether this risk translates to humans remains unknown. Because of this uncertainty, Ozempic is contraindicated for anyone with a personal or family history of medullary thyroid carcinoma or a condition called Multiple Endocrine Neoplasia syndrome type 2. If you have either in your medical or family history, this medication is not an option for you.
Dosing and How You Take It
Ozempic is injected once a week using a prefilled pen, typically in the stomach, thigh, or upper arm. You pick a day of the week and stick with it, though you can shift the day if needed as long as there are at least two days between doses. The injection itself uses a very small needle and takes only a few seconds.
The standard schedule ramps up gradually over several months:
- Weeks 1 through 4: 0.25 mg per week (a starter dose not meant to control blood sugar on its own)
- Week 5 onward: 0.5 mg per week
- If needed: your doctor may increase to 1 mg, and eventually up to the maximum of 2 mg per week
Each increase typically happens after at least four weeks at the current dose. Your doctor will decide how high to go based on your blood sugar response and how well you tolerate the side effects.
Storing Your Pen
Before you use a pen for the first time, keep it in the refrigerator between 36°F and 46°F. It stays good until its printed expiration date as long as it remains refrigerated. Once you start using a pen, you have 56 days before you need to discard it, whether you store it in the fridge or at room temperature (up to 86°F). Never freeze the pen, and discard it if it has been exposed to temperatures below 36°F or above 86°F.
Ozempic vs. Wegovy
The most common point of confusion is the relationship between these two drugs. They contain the exact same active ingredient, semaglutide, made by the same manufacturer. The differences are regulatory and dosing-related. Ozempic maxes out at 2 mg and is prescribed for type 2 diabetes. Wegovy maxes out at 2.4 mg and is prescribed for weight management and cardiovascular risk reduction in people with obesity or overweight. Your insurance coverage, diagnosis, and treatment goals will typically determine which one your doctor prescribes. Using Ozempic “off-label” for weight loss is common but may not be covered by insurance, and the dosing may differ from what has been studied for that purpose.